Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1015 of 5804
-
New therapy combo aims to keep women in opioid recovery
Disease control Recruiting nowUsing a hybrid type 1 effectiveness-implementation approach, this study aims to evaluate the impact of a novel stepped care model ("PCT+2HOPE") versus treatment as usual (TAU) on increasing retention in community-based medication for opioid use disorder (MOUD) treatment among wom…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New infrared scanner aims to spot breast cancer before tumors form
Diagnosis Not yet recruitingWhen we talk about early identification, we are talking about an ALREADY EXISTING INJURY, triggering a change in the patient's quality of life and a projection of future costs for the health system. INNOVATIVE ASPECT: While screening mammography identifies an existing lesion, VT…
Phase: NA • Sponsor: Galzu Institute of Research, Teaching, Science and Applied Technology • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Experimental CAR t therapy takes on tough leukemia
Disease control Recruiting nowThis is a Phase 1, open label, dose-escalation study to evaluate the safety, expansion, persistence, and preliminary clinical activity of lentivirally transduced autologous T cells expressing anti-CD64 chimeric antigen receptors (CAR) expressing tandem CD3ζ and 4-1BB (CD3ζ/4-1BB)…
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Glowing dye could save voices in esophageal cancer surgery
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether the application of indocyanine green near-infrared imaging system can accurately locate the recurrent laryngeal nerve (RLN) during lymph node dissection in esophageal cancer radical surgery, thereby reducing the risk of RLN inju…
Phase: PHASE3 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Gene secrets could explain why heart drug works for some, not others
Knowledge-focused Not yet recruitingThis research study, aims to understand why a specific heart medication called mavacamten works better for some people with hypertrophic cardiomyopathy (HCM) than for others. We believe the answer might be in our genes. The study focuses on two key areas: 1. The specific gene c…
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New combo therapy aims to shrink head and neck tumors
Disease control Recruiting nowThis will be a multi-center, randomized, open-label, parallel-group study in adult patients with head and neck cancer.
Phase: PHASE2 • Sponsor: VSPharmTech Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New radioactive therapy targets mysterious cancers
Disease control Not yet recruitingThe aim of the study is to test if a new radionuclide therapy, called 177-Lu-FAP-2286, works to treat cancer in patients with Cancer of Unknown Primary (CUP).
Phase: PHASE2 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New combo therapy targets breast cancer brain metastases
Disease control Not yet recruitingA phase I clinical trial (a type of research study) for people with human epidermal growth factor receptor 2 (HER-2) positive breast cancer with metastasis to the brain. This research study will evaluate how well brain metastases can be controlled using a type of radiation therap…
Phase: PHASE1 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a night of brain zapping improve sleep and seizures in epilepsy?
Symptom relief Not yet recruitingThe goal of this clinical trial is to gauge whether overnight, non-invasive temporal interference (TI) stimulation aimed at the hippocampus can reduce abnormal brain activity linked to seizures and improve sleep in adults with drug-resistant temporal lobe epilepsy. The main quest…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Teen liver crisis: diet trial offers hope
Disease control Recruiting nowThis phase 2 trial is a single-site sequential, multiple assignment, randomized trial (SMART) to test and construct a high-quality adaptive intervention of essential amino acids (EAA) and/or Low Sugar Diet for children with metabolic dysfunction associated steatotic liver disease…
Phase: PHASE2 • Sponsor: Michigan State University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New pill could tame Hormone-Driven high blood pressure
Disease control Not yet recruitingThis is a Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety, tolerability, and efficacy of QLS1410 versus placebo, on the reduction of Seated Blood Pressure (SBP) in participants ≥ 18 years of age with Primary Aldoste…
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Nasal spray may curb Post-Surgery confusion in seniors
Symptom relief Not yet recruitingThis clinical trial is designed to observe the effect of dexmedetomidine nasal spray on the incidence of postoperative delirium in elderly patients undergoing thoracoscopic lung resection. Eligible elderly patients scheduled for thoracoscopic lung resection will be randomly divid…
Phase: PHASE4 • Sponsor: Sichuan Provincial People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Balloon vs stent: new heart artery trial aims for better outcomes
Disease control Not yet recruitingTo compare the safety and efficacy of Biolimus drug-coated balloon (DCB) versus drug-eluting stent (DES) in the treatment of de novo coronary artery lesions.
Phase: NA • Sponsor: JW Medical Systems Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can a drug curb Self-Harm? new trial aims to find out
Disease control Not yet recruitingThe goal of this clinical trial is to learn if naltrexone works to treat nonsuicidal self-injurious behavior in adolescents and adults.
Phase: PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Light therapy offers hope for kids suffering chemo mouth sores
Symptom relief Not yet recruitingChemotherapy induced oral mucositis is a common and debilitating complication in pediatric patients receiving chemotherapy for hematolymphoid malignancies. Oral mucositis can cause painful mouth ulcers, difficulty in eating and drinking, impaired nutrition, increased risk of infe…
Phase: NA • Sponsor: Tata Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New depression drug DT-101 enters Mid-Stage trial
Symptom relief Recruiting nowIn this study, researchers will learn more about a study drug called DT-101 in participants with Major Depressive Disorder (MDD), a form of depression. The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to p…
Phase: PHASE2 • Sponsor: Draig Therapeutics Ltd • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New diabetes combo pill aims to beat single drugs in major trial
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of initial combination therapy with DWP16001 and DWC202518 compared to DWP16001 monotherapy and DWC202518 monotherapy in patients with Type 2 Diabetes Mellitus
Phase: PHASE3 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Blood thinner may stop organ failure in pancreatitis patients
Disease control Not yet recruitingThis clinical trial is designed to evaluate whether adding a standard blood-thinning medication, Unfractionated Heparin, to standard hospital care can help prevent severe organ failure in patients admitted with acute pancreatitis. Acute pancreatitis is a sudden and severe inflam…
Phase: PHASE4 • Sponsor: Allied Hospital Faisalabad • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Major study to uncover cancer Treatment's hidden toll on fertility
Knowledge-focused Not yet recruitingIn the past two decades, the evidence-based knowledge on the prevalence and risk factors for gonads impairment, including infertility, following cancer and numerous cancer treatment regimen has significantly increased. However, data remains mostly insufficient for individualized …
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Smartwatches could help predict heart failure risks
Knowledge-focused Recruiting nowThe primary objective is to establish a Cleveland Clinic-led registry designed to integrate continuous physiological data from consumer wearables, captured by the HeartBit app and a Case Western Reserve University (CWRU)-based platform, with clinical data from patients' individua…
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC